![]() 971,059,963 visitors served. |
|
![]() Dictionary/ thesaurus | ![]() Medical dictionary | ![]() Legal dictionary | ![]() Financial dictionary | ![]() Acronyms | ![]() Idioms | ![]() Encyclopedia | ![]() Wikipedia encyclopedia | ? |
IIT |
0.40 sec. |
|
|
? References in periodicals archive |
|---|
DF/HCC has more than 400 oncology clinical investigators conducting 133 principal investigator-initiated trials in 2006. NASDAQ:SLXP) today announced results of one investigator-initiated trial of XIFAXAN(R) (rifaximin) tablets 200 mg presented today at Digestive Disease Week(R) 2006. NASDAQ:SLXP) today announced results of two Company-sponsored trials of OSMOPREP(TM) and one investigator-initiated trial of XIFAXAN(R) (rifaximin) tablets 200 mg that were presented today at Digestive Disease Week(R) 2006. |
| Free Tools: |
For surfers:
Browser extension |
Word of the Day |
Help
For webmasters: Free content NEW! | Linking | Lookup box | Double-click lookup | Partner with us |
|
|---|